Summary
Twenty patients with bladder cancer were treated by semiselective intra-arterial chemotherapy with Adriamycin. Ten of them were given the agent while the femoral arteries were compressed, to prevent loss of the agent into the external iliac arteries. The other ten were given Adriamycin without this compression. Clinical and pathological responses of tumor and the side-effects were examined in these two groups. The results of the comparative study led us to the conclusion that the compression technique is a simple and valuable means of decreasing the side-effects of Adriamycin and increasing tumor response.
Similar content being viewed by others
References
Arcamone F, Casinelli G, Franceschi G et al. (1972) Structure and physiochemical properties of Adriamycin (doxorubicin). In: Carter SK, Di Marco A, Ghione M et al. (eds) International Symposium on Adriamycin. Springer, Berlin Heidelberg New York, p 9
Benjamin RS (1975) A practical approach to Adriamycin (NSC-123127) toxicity. Cancer Chemother Rep [1] 6: 191
Blum AH, Carter SK (1974) Adriamycin: A new anticancer drug with significant clinical activity. Ann Intern Med 80: 245
Bonadonna G, Monfardini S, De Lena M et al. (1970) Phase I and preliminary phase II evaluation of Adriamycin (NSC-123127). Cancer Res 30: 2572
Bonadonna G, Bereta G, Tancini G et al. (1975) Adriamycin (NSC-123127) studies at the Instituto Nazionale Tumori, Milan. Cancer Chemother Rep [3] 6: 231
Bristow MR, Billingham ME, Mason JW, Daniels JR (1978) Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 62: 837
Carter SK (1975) Adriamycin — A review. J Natl Cancer Inst 55: 1265
Cross RJ, Glashian RE, Humphrey CS et al. (1976) Treatment of advanced bladder cancer with Adriamycin and 5-fluorouracil. Br J Urol 48: 609
De Wys WD, Begg CB (1978) Comparison of Adriamycin (adria) and 5-fluorouracil (5FU) in advanced prostatic cancer. Proc AACR/ASCO 19: 331
Donaldson SS, Glick JM, Wilbur JR (1974) Adriamycin activating a recall phenomenon after radiation therapy. Ann Intern Med 81: 407
Iguchi M, Matsuura T, Minami K, Kurita T (1979) Evaluation of superselective intra-arterial administration therapy with Adriamycin against progressive bladder cancer. In: Niijima T (ed) Proceedings of the First Conference on Treatment of Urinary Tract Tumors with Adriamycin. Kyowa Hakko Kogyo, Tokyo p 145
Kimura K, Fujita H, Sasaki Y (1972) Blood levels, tissue distribution and clinical effects of Adriamycin. In: Carter SK, Di Marco A, Ghione M et al. (eds) Proceedings of the Internation Symposium on Adriamycin. Springer, Berlin Heidelberg New York, p 124
Myers CE, McGuire WP, Liss RH et al. (1977) Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response. Science 197: 165
Nakamura T (1969) Studies on the chemotherapy of cancer of urinary bladder. I. Clinical studies on treatment with continuous infusion of anticancer agent into the internal iliac artery. Jpn J Urol 60: 633
Nevin JE, Melnik I, Baggerly JT et al. (1974) Advanced carcinoma of bladder: Treatment using hypogastric artery infusion with 5-fluorouracil, either as a single agent or in combination with bleomycin or Adriamycin and supervoltage radiation. J Urol 112: 752
Poulakos L, Schenken LL, Hagemann RF et al. (1975) Control of local tumor growth with combined fractionated radiotherapeutic and chemotherapeutic regimens. J Natl Cancer Inst 54: 1103
Shimosato Y, Oboshi S, Baba K (1971) Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1: 19
Uyama T, Moriwaki S (1979) Treatment of cancers of the urinary organ by intra-arterial infusion of Adriamycin. In: Niijima T (ed) Proceedings of the First Conference on Treatment of Urinary Tract Tumors with Adriamycin. Kyowa Hakko Kogyo, Tokyo p 154
Whitemore WF (1974) Guest editorial. J Urol 112: 678
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uyama, T., Moriwaki, S., Yonezawa, M. et al. Intra-arterial Adriamycin chemotherapy for bladder cancer. Cancer Chemother. Pharmacol. 11 (Suppl 1), S59–S63 (1983). https://doi.org/10.1007/BF00256720
Issue Date:
DOI: https://doi.org/10.1007/BF00256720